Identification of the null HLA-A2 allele, A*0232N

被引:22
作者
Bunce, M [1 ]
Procter, J
Dunn, PPJ
Day, S
Ross, J
Welsh, KI
机构
[1] Churchill Hosp, Nuffield Dept Surg, Oxford Transplant Ctr, Oxford OX3 7LJ, England
[2] United Kingdom Transplant Support Serv Author, Bristol, Avon, England
来源
TISSUE ANTIGENS | 2000年 / 55卷 / 01期
关键词
HLA-A*0232N; null allele; PCR-SSP; point mutation;
D O I
10.1034/j.1399-0039.2000.550105.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We have identified a null HLA-A*02 allele, HLA-A*0232N, by using a combination of serology, flow cytometry, polymerase chain reaction using sequence-specific primers (PCR-SSP) and full-length sequencing, The null HLA-A2 allele was identified in an Asian individual originally typed by serology as an apparently homozygous HLA-A3, B51. Subsequent genotyping by PCR-SSP identified the genotype as HLA-A*0201, *0301, B*51, Cw*1402. The serological type and lack of delectable HLA-A2 was confirmed using monoclonal antibody typing reagents, Flow cytometry studies failed to identify any cell surface HLA-A2 expression on the patient's pe ripheral blood lymphocytes, Genotyping using a PCR-SSP set designed to detect null alleles revealed the mutation had not been previously described. Full-length sequencing of the allele identified an allele which was subsequently named HLA-A*0232N. This allele is identical to HLA-A*0201 except for a novel point mutation (T for C) at position 493 which creates a premature stop codon, The sequencing enabled the development of a monospecific A*0232N PCR-SSP reaction which was used to screen 973 DNA samples: no further examples of A*0232N were identified.
引用
收藏
页码:31 / 36
页数:6
相关论文
共 22 条
  • [1] HLA CLASS-I ALLELE (HLA-A2) EXPRESSION DEFECT ASSOCIATED WITH A MUTATION IN ITS ENHANCER-B INVERTED CAT BOX IN 2 FAMILIES
    BALAS, A
    GARCIASANCHEZ, F
    GOMEZREINO, F
    VICARIO, JL
    [J]. HUMAN IMMUNOLOGY, 1994, 41 (01) : 69 - 73
  • [2] Phototyping: Comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP)
    Bunce, M
    ONeill, CM
    Barnardo, MCNM
    Krausa, P
    Browning, MJ
    Morris, PJ
    Welsh, KI
    [J]. TISSUE ANTIGENS, 1995, 46 (05): : 355 - 367
  • [3] A DNA-based detection and screening system for identifying HLA class I expression variants by sequence-specific primers
    Bunce, M
    Procter, J
    Welsh, KI
    [J]. TISSUE ANTIGENS, 1999, 53 (05): : 498 - 506
  • [4] LOCUS-SPECIFIC AMPLIFICATION OF HLA CLASS-I GENES FROM GENOMIC DNA - LOCUS-SPECIFIC SEQUENCES IN THE FIRST AND 3RD INTRONS OF HLA-A, HLA-B, AND HLA-C ALLELES
    CEREB, N
    MAYE, P
    LEE, S
    KONG, Y
    YANG, SY
    [J]. TISSUE ANTIGENS, 1995, 45 (01): : 1 - 11
  • [5] Aberrant splicing of intron 1 creates a novel null HLA-B*1501 allele
    Curran, MD
    Williams, F
    Little, AM
    Rima, BK
    Madrigal, JA
    Middleton, D
    [J]. TISSUE ANTIGENS, 1999, 53 (03): : 244 - 252
  • [6] DOMENA JD, 1993, TISSUE ANTIGENS, V42, P509
  • [7] Ishikawa Y, 1996, IMMUNOGENETICS, V43, P1
  • [8] KOLLER BH, 1985, J IMMUNOL, V134, P2727
  • [9] Sequencing of HLA class I genes based on the conserved diversity of the noncoding regions: sequencing-based typing of the HLA-A gene
    Kotsch, K
    Wehling, J
    Kohler, S
    Blasczyk, R
    [J]. TISSUE ANTIGENS, 1997, 50 (02): : 178 - 191
  • [10] A nucleotide insertion in exon 4 is responsible for the absence of expression of an HLA-A*01 allele
    Laforet, M
    Froelich, N
    Parissiadis, A
    Pfeiffer, B
    Schell, A
    Faller, B
    WoehlJaegle, ML
    Cazenave, JP
    Tongio, MM
    [J]. TISSUE ANTIGENS, 1997, 50 (04): : 347 - 350